Luminist Labs

Overview

Luminist Labs was a diagnostic platform for early detection of liver disease [1] based in New York City, NY, USA [2]. The company went through Y Combinator in the Winter 2016 batch [3] and operated with a team size of 2 [4]. Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH) [5]. The company was acquired in 2020 by DiscernDx [6].

Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx. [5]

Y Combinator's directory lists the company location as New York City, NY, USA. [2]

Growth & traction

Y Combinator lists a team size of 2. [1]